Cargando…
How Compounding Pharmacies Fill Critical Gaps in Pediatric Drug Development Processes: Suggested Regulatory Changes to Meet Future Challenges
Drugs administered to children in the United States fall into two broad categories: (1) those that have followed the US Food and Drug Administration (US-FDA) pediatric drug approval process and are marketed as finished dosage forms with pediatric labeling; and (2) all others, many of which are used...
Autores principales: | MacArthur, Robert B., Ashworth, Lisa D., Zhan, Keming, Parrish, Richard H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777176/ https://www.ncbi.nlm.nih.gov/pubmed/36553327 http://dx.doi.org/10.3390/children9121885 |
Ejemplares similares
-
Will Organoids Fill the Gap towards Functional Precision Medicine?
por: Papaccio, Federica, et al.
Publicado: (2022) -
Pediatric laboratory developed tests filling the gaps for children in crisis
por: Bunch, Dustin R.
Publicado: (2023) -
Potential Risks of Pharmacy Compounding
por: Gudeman, Jennifer, et al.
Publicado: (2013) -
Pharmacy Compounding Primer for Physicians: Prescriber Beware
por: Sellers, Sarah, et al.
Publicado: (2012) -
Inclusion of gametocyte parameters in anti-malarial drug efficacy studies: filling a neglected gap needed for malaria elimination
por: Abdul-Ghani, Rashad, et al.
Publicado: (2015)